Skip to main content

and
  1. No Access

    Article

    Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight

    With recent advances in targeted therapy such as tyrosine kinase inhibitor (TKI) therapy for non-small cell lung cancer (NSCLC), pulmonary toxicity has emerged as a problem. The recognition of common CT findin...

    Ji Hye Min, Ho Yun Lee, Hoyeong Lim, Myung-Ju Ahn in Cancer Chemotherapy and Pharmacology (2011)